Related Articles
FLOW CYTOMETRIC DNA ANALYSIS IN PREDICTION OF INTRAVESICAL RECURRENCE FROM HUMAN BLADDER-CANCER
PROGNOSTIC VALUE OF P53 EXPRESSION IN EARLY-STAGE BREAST-CARCINOMA COMPARED WITH TUMOR ANGIOGENESIS, EPIDERMAL GROWTH-FACTOR RECEPTOR, C-ERBB-2, CATHEPSIN-D, DNA-PLOIDY, PARAMETERS OF CELL-KINETICS AND CONVENTIONAL FEATURES
p53 protein overexpression is a prognostic indicator of poor survival in stage I endometrial carcinoma.
EV20‑sss‑vc/MMAF, an HER‑3 targeting antibody‑drug conjugate displays antitumor activity in liver cancer
Six autoantibodies as potential differential biomarkers of hepatocellular carcinoma vs. liver cirrhosis and chronic hepatitis: A prospective multi‑institutional study